Article Figures & Tables
Tables
- Table 1: Proportion of provincial drug plan enrollees aged 65 years or more who filled 1 or more potentially inappropriate prescription* in 2013, by province, sex and age group
Province Population (%) aged ≥ 65 yr covered by NPDUIS database Age, yr; no. (%) of enrollees Women Men Overall 65-74 75-84 ≥ 85 All ages 65-74 75-84 ≥ 85 All ages British Columbia 769 993 (89.0) 89 636 (41.5) 57 288 (44.6) 34 735 (50.1) 181 659 (43.9) 58 678 (28.8) 39 299 (34.5) 16 049 (41.2) 114 026 (32.0) 295 685 (38.4) Alberta 411 322 (91.7) 54 514 (46.5) 34 388 (47.6) 16 304 (47.0) 105 206 (46.9) 33 675 (31.5) 21 163 (35.0) 7 267 (37.0) 62 105 (33.2) 167 311 (40.7) Saskatchewan 149 505 (93.5) 14 672 (39.4) 11 764 (42.8) 8 762 (46.9) 35 198 (42.2) 9 455 (27.0) 7 166 (32.5) 3 246 (35.9) 19 867 (30.1) 55 065 (36.8) Manitoba 171 195 (93.8) 19 942 (43.3) 13 606 (44.8) 9 209 (46.3) 42 757 (44.4) 12 905 (30.8) 8 353 (35.0) 3 501 (38.1) 24 759 (33.0) 67 516 (39.4) Ontario 1 971 856 (95.9) 200 391 (36.7) 152 241 (43.0) 89 780 (46.1) 442 412 (40.4) 128 933 (26.2) 96 492 (33.8) 39 125 (38.9) 264 550 (30.2) 706 962 (35.8) New Brunswick 73 482 (55.2) 10 650 (55.3) 8 238 (57.3) 5 969 (61.0) 24 857 (57.2) 6 591 (40.6) 4 689 (44.6) 1 690 (50.9) 12 970 (43.1) 37 827 (51.5) Nova Scotia 112 780 (67.5) 15 000 (47.0) 10 303 (49.0) 6 559 (49.7) 31 862 (48.2) 10 039 (37.3) 6 539 (42.8) 2 013 (45.3) 18 591 (39.9) 50 453 (44.7) Prince Edward Island 23 051 (91.8) 2 208 (33.6) 1 393 (34.6) 784 (36.8) 4 385 (34.5) 1 324 (21.5) 813 (25.0) 199 (21.9) 2 336 (22.6) 6 721 (29.2) Newfoundland and Labrador 49 310 (54.9) 7 658 (56.0) 5 787 (58.0) 3 153 (60.1) 16 598 (57.4) 5 383 (48.5) 3 762 (51.8) 1 097 (53.5) 10 242 (50.2) 26 840 (54.4) All high-data-coverage provinces† 3 496 922 (92.6) 381 363 (39.4) 270 680 (43.9) 159 574 (47.0) 811 617 (42.2) 244 970 (27.7) 173 286 (34.1) 69 387 (38.9) 487 643 (31.0) 1 299 260 (37.2) Note: NPDUIS = National Prescription Drug Utilization Information System.
*All prescriptions meeting the Beers Criteria based on drug, dosage and duration.1
†Provinces in which at least 85% of the population aged 65 years or more is covered by the NPDUIS database: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Prince Edward Island.
- Table 2: Average cost per enrollee of potentially inappropriate prescriptions, by province, sex and age
Province Age, yr; average cost, $* Women Men Overall 65-74 75-84 ≥ 85 All ages 65-74 75-84 ≥ 85 All ages British Columbia 84 83 92 85 64 64 69 65 76 Alberta 101 98 101 100 62 66 71 64 84 Saskatchewan 91 90 92 91 67 68 71 68 81 Manitoba 103 98 91 99 73 76 74 74 88 Ontario 67 82 111 80 55 66 84 62 72 New Brunswick 148 142 162 149 110 109 132 112 134 Nova Scotia 102 100 101 101 88 96 97 91 97 Prince Edward Island 60 58 60 60 37 40 28 37 49 Newfoundland and Labrador 134 129 138 133 122 117 126 121 128 All high-data-coverage provinces 78 85 104 85 59 66 78 63 75 *Includes public and private shares of total ingredient costs and dispensing fees for eligible prescriptions under provincial drug benefit programs.
- Table 3: Proportion of enrollees who filled 1 or more potentially inappropriate prescription for the 20 most frequently used drugs on the Beers list and estimated average per-capita cost, by sex
Drug % of enrollees who filled ≥ 1 potentially inappropriate prescription Estimated average per-capita cost of potentially inappropriate prescriptions, $ Women Men Overall Women Men Overall Lorazepam 11.0 6.1 8.8 6.95 3.46 5.40 Nitrofurantoin 8.3 1.9 5.5 3.23 0.75 2.13 Amitriptyline 3.9 2.0 3.1 4.12 1.85 3.11 Quetiapine 2.8 2.2 2.5 8.24 5.95 7.22 Clonazepam 3.0 1.9 2.5 3.02 1.82 2.49 Zopiclone 2.9 1.9 2.4 5.25 3.50 4.47 Conjugated estrogens 4.2 0.0 2.4 3.71 - 2.06 Glibenclamide 1.7 2.7 2.2 1.80 2.52 2.12 Indomethacin 0.7 2.6 1.6 0.30 1.09 0.65 Terazosin 0.4 2.9 1.5 0.82 5.04 2.70 Oxazepam 1.8 1.1 1.5 1.61 0.84 1.27 Risperidone 1.6 1.1 1.4 5.48 3.64 4.66 Estradiol 2.6 0.0 1.4 5.95 - 3.31 Temazepam 1.6 1.2 1.4 1.41 0.96 1.21 Metoclopramide 1.3 1.0 1.2 0.65 0.45 0.56 Amiodarone 0.7 1.1 0.9 1.41 2.26 1.79 Meloxicam 1.1 0.6 0.9 1.65 0.93 1.33 Cyclobenzaprine 1.0 0.9 0.9 0.54 0.40 0.48 Diclofenac, combinations 0.8 0.8 0.8 3.98 3.59 3.80 Alprazolam 1.1 0.6 0.8 0.96 0.49 0.75 - Table 4: Estimated total cost of potentially inappropriate prescriptions filled by older Canadians in 2013
Variable Women Men Overall Estimated average cost per enrollee, $ 84.60 63.40 75.00 National population of age/sex group 3 064 000 2 521 000 5 585 000 Estimated total cost, $ millions 259 160 419
In this issue
Article tools
Respond to this article
Related Articles
Cited By...
- Evaluating the effectiveness of the Smart About Meds (SAM) mobile application among patients discharged from hospital: protocol of a randomised controlled trial
- Improving Medication Prescribing-Related Outcomes for Vulnerable Elderly In Transitions on High Risk Medications (IMPROVE-IT HRM): A Pilot Randomized Trial Protocol
- Inappropriate use of clinical practices in Canada: a systematic review
- Medication use and its impact on high-cost health care users among older adults: protocol for the population-based matched cohort HiCOSTT study
- Potentially inappropriate medications in older patients based on Beers criteria: a cross-sectional study of a family medicine practice in Saudi Arabia